Royal Bank of Canada

Selected news for the capital firm - Royal Bank of Canada, collected since 10/2017. Recent stories appear in baseballnewssource.com. This capital firm shares healthcare news with Benefitfocus, Bausch Health, BioCryst, HealthEquity and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
4/23/2021 DZ Bank Reiterates “Buy” Rating for Siemens Aktiengesellschaft (OTCMKTS:SIEGY) baseballnewssource.com ... rating on shares of Siemens Aktiengesellschaft in a research note on Monday, April 12th. UBS Group reiterated a “buy” rating on shares of Siemens Aktiengesellschaft in a research note on Tuesday, April 13th. Royal Bank of Canada reiterated an “outperform” rating on shares of Siemens Aktiengesellschaft in a research note on Wednesday, January 6th. Finally, Citigroup reiterated a “buy” rating on shares of Siemens Aktiengesellschaft in a ...
4/23/2021 Morgan Stanley Raises Amgen (NASDAQ:AMGN) Price Target to $281.00 baseballnewssource.com ... research analysts also recently weighed in on the company. JPMorgan Chase & Co. set a $222.00 target price on Amgen and gave the stock a neutral rating in a research report on Thursday, March 4th. Royal Bank of Canada restated a neutral rating on shares of Amgen in a research report on Monday, January 4th. SVB Leerink boosted their target price on Amgen from $252.00 to $260.00 and gave the stock ...
4/23/2021 Piper Sandler Brokers Raise Earnings Estimates for Amgen Inc. (NASDAQ:AMGN) zolmax.com ... gave the company a “buy” rating in a research report on Thursday, March 4th. Oppenheimer boosted their target price on Amgen from $266.00 to $275.00 in a research report on Monday, April 5th. Royal Bank of Canada restated a “neutral” rating on shares of Amgen in a research report on Monday, January 4th. Cantor Fitzgerald boosted their target price on Amgen from $280.00 to $295.00 and gave the ...
4/23/2021 Surgery Partners (NASDAQ:SGRY) Stock Price Up 8.4% rivertonroll.com ... hands during mid-day trading, a decline of 97% from the average daily volume of 466,316 shares. The stock had previously closed at $42.60.SGRY has been the subject of several recent research reports. Royal Bank of Canada increased their price objective on shares of Surgery Partners from $36.00 to $54.00 and gave the company an “outperform” rating in a research report on Thursday, March 11th. Zacks Investment Research ...
4/23/2021 Aegon (NYSE:AEG) Stock Rating Upgraded by Zacks Investment Research - Watch List News watchlistnews.com ... Get Aegon alerts: A number of other equities research analysts have also weighed in on the stock. Berenberg Bank reiterated a buy rating on shares of Aegon in a report on Thursday, March 25th. Royal Bank of Canada restated a sector perform rating on shares of Aegon in a report on Tuesday, March 9th. Kepler Capital Markets reissued a hold rating on shares of Aegon in a research report on ...
4/23/2021 Aegon (NYSE:AEG) Stock Rating Upgraded by Zacks Investment Research - Ticker Report Ticker Report ... equal weight rating on shares of Aegon in a research note on Tuesday, March 30th. HSBC downgraded Aegon from a buy rating to a hold rating in a research note on Friday, January 8th. Royal Bank of Canada restated a sector perform rating on shares of Aegon in a report on Tuesday, March 9th. Societe Generale restated a sell rating on shares of Aegon in a report on Friday, February ...
4/19/2021 NextGen Healthcare, Inc. (NASDAQ:NXGN) Given Average Rating of “Hold” by Brokerages Mayfield Recorder ... shares of NextGen Healthcare from a “neutral” rating to an “overweight” rating and raised their target price for the company from $20.00 to $23.00 in a research note on Friday, February 19th. Royal Bank of Canada increased their price objective on shares of NextGen Healthcare from $14.00 to $21.00 and gave the stock a “positive” rating in a research report on Thursday, January 14th. Morgan Stanley increased ...
4/19/2021 Deutsche Bank Aktiengesellschaft Boosts PepsiCo (NASDAQ:PEP) Price Target to $147.00 rivertonroll.com ... peer perform rating for the company. Sanford C. Bernstein initiated coverage on PepsiCo in a research note on Tuesday, January 19th. They set an underperform rating and a $136.00 price objective for the company. Royal Bank of Canada cut shares of PepsiCo from an outperform rating to a sector perform rating and set a $153.00 price objective on the stock. in a research note on Monday, January 4th. They noted ...
4/19/2021 PepsiCo (NASDAQ:PEP) PT Raised to $155.00 slatersentinel.com ... in a research report sent to investors on Friday, Price Targets.com reports. Credit Suisse Group currently has an outperform rating on the stock.A number of other brokerages have also recently commented on PEP. Royal Bank of Canada cut shares of PepsiCo from an outperform rating to a sector perform rating and set a $153.00 price target for the company. in a research note on Monday, January 4th. They noted ...
4/19/2021 Toll Brothers (NYSE:TOL) Earns Overweight Rating from Analysts at Wells Fargo & Company transcriptdaily.com ... Monday, March 22nd. They set a peer perform rating for the company. Argus raised their target price on shares of Toll Brothers from $56.00 to $62.00 in a report on Tuesday, March 2nd. Finally, Royal Bank of Canada raised their target price on shares of Toll Brothers from $50.00 to $60.00 and gave the stock an outperform rating in a report on Thursday, February 25th. Four equities research analysts have ...
4/19/2021 Zacks Investment Research Downgrades Ovid Therapeutics (NASDAQ:OVID) to Hold dispatchtribunal.com ... Company Limited for the treatment of rare epileptic encephalopathies. Ovid Therapeutics Inc. is based in New York, United States. “ Get Ovid Therapeutics alerts:Other analysts have also issued research reports about the stock. Royal Bank of Canada lowered shares of Ovid Therapeutics from an “outperform” rating to a “sector perform” rating and set a $5.00 price objective for the company. in a research note on Wednesday, March ...
4/19/2021 Ionis Pharmaceuticals (NASDAQ:IONS) Hits New 1-Year Low Following Analyst Downgrade zolmax.com ... A number of other equities analysts also recently issued reports on the company. TheStreet downgraded Ionis Pharmaceuticals from a “c” rating to a “d+” rating in a report on Wednesday, February 24th. Royal Bank of Canada decreased their price objective on Ionis Pharmaceuticals from $76.00 to $65.00 and set an “outperform” rating for the company in a report on Tuesday, March 23rd. UBS Group reiterated a “reduce ...
4/15/2021 ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Rating Reaffirmed by The Goldman Sachs Group Daily Political ... target price of $73.00. The Goldman Sachs Group’s price target points to a potential upside of 17.48% from the stock’s current price.ACAD has been the subject of several other research reports. Royal Bank of Canada decreased their price objective on shares of ACADIA Pharmaceuticals from $60.00 to $36.00 and set an “outperform” rating for the company in a research note on Tuesday, March 9th. Zacks Investment ...
4/15/2021 Tri Pointe Homes, Inc. (NYSE:TPH) Receives Consensus Recommendation of “Buy” from Brokerages Ticker Report ... TPH shares. Janney Montgomery Scott started coverage on shares of Tri Pointe Homes in a report on Thursday, January 21st. They set a “buy” rating and a $26.00 price objective on the stock. Royal Bank of Canada downgraded shares of Tri Pointe Homes from an “outperform” rating to a “sector perform” rating and dropped their price objective for the company from $22.00 to $19.00 in a report ...
4/15/2021 Karyopharm Therapeutics (NASDAQ:KPTI) Reaches New 52-Week Low at $9.75 Daily Political ... Several equities research analysts have issued reports on KPTI shares. Zacks Investment Research lowered Karyopharm Therapeutics from a “hold” rating to a “sell” rating in a research note on Thursday, February 18th. Royal Bank of Canada reaffirmed a “buy” rating and set a $24.00 price target on shares of Karyopharm Therapeutics in a research note on Sunday. SVB Leerink dropped their price target on Karyopharm Therapeutics from ...
4/12/2021 Karyopharm Therapeutics (NASDAQ:KPTI) Receives “Buy” Rating from Royal Bank of Canada Daily Political Karyopharm Therapeutics (NASDAQ:KPTI) ‘s stock had its “buy” rating reissued by stock analysts at Royal Bank of Canada in a report released on Sunday, AnalystRatings.com reports. They presently have a $24.00 price target on the stock. Royal Bank of Canada’s target price indicates a potential upside of 139.52% from the stock’s current price.Several other analysts have also commented on the company. SVB Leerink dropped their price ...
4/12/2021 Karyopharm Therapeutics’ (KPTI) “Buy” Rating Reaffirmed at Royal Bank of Canada zolmax.com Karyopharm Therapeutics’ (KPTI) “Buy” Rating Reaffirmed at Royal Bank of Canada Posted by Stuart HamKaryopharm Therapeutics (NASDAQ:KPTI) ‘s stock had its “buy” rating restated by investment analysts at Royal Bank of Canada in a research note issued on Sunday, AnalystRatings.com reports. They currently have a $24.00 price target on the stock. Royal Bank of Canada’s target price suggests a potential upside of 139.52% from ...
4/11/2021 Option Care Health (NASDAQ:OPCH) Sees Large Volume Increase Daily Political HSBC (LON:HSBA) Given a GBX 465 Price Target at Royal Bank of Canada Option Care Health (NASDAQ:OPCH) Sees Large Volume Increase April 10th, 2021 - Comments Off on Option Care Health (NASDAQ:OPCH) Sees Large Volume Increase - Filed Under - by Tyrone Williams TweetOption Care Health, Inc. (NASDAQ:OPCH) saw unusually-high trading volume on Friday . Approximately 35,239 shares traded hands during trading, a decline of 97% from the ...
4/11/2021 Spire Healthcare Group (LON:SPI) PT Raised to GBX 200 at Royal Bank of Canada Mayfield Recorder Spire Healthcare Group (LON:SPI) PT Raised to GBX 200 at Royal Bank of Canada Posted by Sean Solarzano on Apr 11th, 2021Spire Healthcare Group (LON:SPI) had its target price upped by Royal Bank of Canada from GBX 169 ($2.21) to GBX 200 ($2.61) in a research note published on Thursday, Digital Look reports. The brokerage currently has an outperform rating on the stock.Separately, Liberum Capital downgraded ...
4/10/2021 Zacks Investment Research Lowers Healthcare Services Group (NASDAQ:HCSG) to Sell Daily Political ... clients. Flexible and responsive, our people are trained to help you achieve success by delivering innovative solutions, exceptional performance and measurable results. “HCSG has been the subject of a number of other research reports. Royal Bank of Canada boosted their target price on shares of Healthcare Services Group from $24.00 to $30.00 and gave the company a sector perform Thursday, February 11th. TheStreet raised shares of Healthcare Services Group from ...